Related references
Note: Only part of the references are listed.Shaping mitochondrial dynamics: The role of cAMP signalling
Giulietta Di Benedetto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Use of luciferase probes to measure ATP in living cells and animals
Giampaolo Morciano et al.
NATURE PROTOCOLS (2017)
Water-Soluble Coenzyme Q10 Reduces Rotenone-Induced Mitochondrial Fission
Hai-Ning Li et al.
NEUROCHEMICAL RESEARCH (2017)
Role of LRRK2 in the regulation of dopamine receptor trafficking
Mauro Rassu et al.
PLOS ONE (2017)
Cross-talk between LRRK2 and PKA: implication for Parkinson's disease?
Elisa Greggio et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2017)
LRRK2 mouse models: dissecting the behavior, striatal neurochemistry and neurophysiology of PD pathogenesis
Mattia Volta et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2017)
DAT imaging and clinical biomarkers in relatives at genetic risk for LRRK2R1441G Parkinson's disease
Alberto Bergareche et al.
MOVEMENT DISORDERS (2016)
Early alterations of mitochondrial morphology in dopaminergic neurons from Parkinson's disease-like pathology and time-dependent neuroprotection with D2 receptor activation
Lyle Wiemerslage et al.
MITOCHONDRION (2016)
Function and dysfunction of leucine-rich repeat kinase 2 (LRRK2): Parkinson's disease and beyond
Jae Ryul Bae et al.
BMB REPORTS (2015)
Defective autophagy is a key feature of cerebral cavernous malformations
Saverio Marchi et al.
EMBO MOLECULAR MEDICINE (2015)
Selective expression of Parkinson's disease-related Leucine-rich repeat kinase 2 G2019S missense mutation in midbrain dopaminergic neurons impairs dopamine release and dopaminergic gene expression
Guoxiang Liu et al.
HUMAN MOLECULAR GENETICS (2015)
Behavioral, neurochemical, and pathologic alterations in bacterial artificial chromosome transgenic G2019S leucine-rich repeated kinase 2 rats
Jang-Won Lee et al.
NEUROBIOLOGY OF AGING (2015)
An early axonopathy in a hLRRK2(R1441G) transgenic model of Parkinson disease
Patricia Tagliaferro et al.
NEUROBIOLOGY OF DISEASE (2015)
Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice
M. Yue et al.
NEUROBIOLOGY OF DISEASE (2015)
Clinical and imaging markers in premotor LRRK2 G2019S mutation carriers
Dolores Vilas et al.
PARKINSONISM & RELATED DISORDERS (2015)
LRRK2 overexpression alters glutamatergic presynaptic plasticity, striatal dopamine tone, postsynaptic signal transduction, motor activity and memory
Dayne A. Beccano-Kelly et al.
HUMAN MOLECULAR GENETICS (2015)
Role of soluble adenylyl cyclase in mitochondria
Federica Valsecchi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Pharmacological Treatment of Parkinson Disease A Review
Barbara S. Connolly et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Paradoxical Abatement of Striatal Dopaminergic Transmission by Cocaine and Methylphenidate
Mauro Federici et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Differential LRRK2 Expression in the Cortex, Striatum, and Substantia Nigra in Transgenic and Nontransgenic Rodents
Andrew B. West et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2014)
LRRK2 pathobiology in Parkinson's disease
Ian Martin et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Direct and indirect pathways of basal ganglia: a critical reappraisal
Paolo Calabresi et al.
NATURE NEUROSCIENCE (2014)
Conditional expression of Parkinson's disease-related R1441C LRRK2 in midbrain dopaminergic neurons of mice causes nuclear abnormalities without neurodegeneration
Elpida Tsika et al.
NEUROBIOLOGY OF DISEASE (2014)
Interferon-β1a protects neurons against mitochondrial toxicity via modulation of STAT1 signaling: Electrophysiological evidence
Massimiliano Di Filippo et al.
NEUROBIOLOGY OF DISEASE (2014)
Genetic and pharmacological evidence that G2019S LRRK2 confers a hyperkinetic phenotype, resistant to motor decline associated with aging
Francesco Longo et al.
NEUROBIOLOGY OF DISEASE (2014)
The neuroprotective effect of human uncoupling protein 2 (hUCP2) requires cAMP-dependent protein kinase in a toxin model of Parkinson's disease
Ran-Der Hwang et al.
NEUROBIOLOGY OF DISEASE (2014)
LRRK2 R1441G mice are more liable to dopamine depletion and locomotor inactivity
Hui-Fang Liu et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2014)
Subcellular calcium measurements in mammalian cells using jellyfish photoprotein aequorin-based probes
Massimo Bonora et al.
NATURE PROTOCOLS (2013)
Olfaction and imaging biomarkers in premotor LRRK2 G2019S-associated Parkinson disease
Maria Sierra et al.
NEUROLOGY (2013)
Monogenic Parkinson's disease and parkinsonism: Clinical phenotypes and frequencies of known mutations
Andreas Puschmann
PARKINSONISM & RELATED DISORDERS (2013)
LRRK2 Affects Vesicle Trafficking, Neurotransmitter Extracellular Level and Membrane Receptor Localization
Rossana Migheli et al.
PLOS ONE (2013)
Cyclic AMP is both a pro-apoptotic and anti-apoptotic second messenger
P. A. Insel et al.
ACTA PHYSIOLOGICA (2012)
Animal models of the non-motor features of Parkinson's disease
Kimberly McDowell et al.
NEUROBIOLOGY OF DISEASE (2012)
Mitochondrial Biology and Parkinson's Disease
Celine Perier et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice
Martin C. Herzig et al.
HUMAN MOLECULAR GENETICS (2011)
Temporal Expression of Mutant LRRK2 in Adult Rats Impairs Dopamine Reuptake
Hongxia Zhou et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2011)
Clinical and brain imaging characteristics in leucine-rich repeat kinase 2-associated PD and asymptomatic mutation carriers
Kathrin Brockmann et al.
MOVEMENT DISORDERS (2011)
A Tale on Animal Models of Parkinson's Disease
Erwan Bezard et al.
MOVEMENT DISORDERS (2011)
Neuroprotective Role of Dopamine Agonists
Maria Trinidad Herrero et al.
NEUROLOGIST (2011)
Mouse models for LRRK2 Parkinson's disease
Qing Xu et al.
PARKINSONISM & RELATED DISORDERS (2011)
Dopaminergic Neuronal Loss, Reduced Neurite Complexity and Autophagic Abnormalities in Transgenic Mice Expressing G2019S Mutant LRRK2
David Ramonet et al.
PLOS ONE (2011)
Gene-environment interactions: Key to unraveling the mystery of Parkinson's disease
Hui-Ming Gao et al.
PROGRESS IN NEUROBIOLOGY (2011)
Downstream mechanisms triggered by mitochondrial dysfunction in the basal ganglia: From experimental models to neurodegenerative diseases
Paolo Gubellini et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
Enhanced Striatal Dopamine Transmission and Motor Performance with LRRK2 Overexpression in Mice Is Eliminated by Familial Parkinson's Disease Mutation G2019S
Xianting Li et al.
JOURNAL OF NEUROSCIENCE (2010)
Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice
H. L. Melrose et al.
NEUROBIOLOGY OF DISEASE (2010)
Mitochondrial impairment in patients with Parkinson disease with the G2019S mutation in LRRK2
Heather Mortiboys et al.
NEUROLOGY (2010)
Chronic ethanol exposure changes dopamine D2 receptor splicing during retinoic acid-induced differentiation of human SH-SY5Y cells
Catrin Wernicke et al.
PHARMACOLOGICAL REPORTS (2010)
Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of α-synuclein, and apoptotic cell death in aged mice
Youren Tong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Mitochondria-targeted antioxidant effects of S(-) and R(+) pramipexole
Giulia Ferrari-Toninelli et al.
BMC Pharmacology & Toxicology (2010)
LRRK2 Modulates Vulnerability to Mitochondrial Dysfunction in Caenorhabditis elegans
Shamol Saha et al.
JOURNAL OF NEUROSCIENCE (2009)
Mutant LRRK2R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's disease
Yanping Li et al.
NATURE NEUROSCIENCE (2009)
Environmental toxins and Parkinson's disease: what have we learned from pesticide-induced animal models?
Francesca Cicchetti et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
D2/D3 receptor agonist ropinirole protects dopaminergic cell line against rotenone-induced apoptosis through inhibition of caspase- and JNK-dependent pathways
Sheng Chen et al.
FEBS LETTERS (2008)
Electrophysiology and pharmacology of striatal neuronal dysfunction induced by mitochondrial complex I inhibition
Cinzia Costa et al.
JOURNAL OF NEUROSCIENCE (2008)
Update on the functional biology of Lrrk2
Heather Melrose
FUTURE NEUROLOGY (2008)
Site specific phosphorylation of cytochrome c oxidase subunits I, IVi1 and Vb in rabbit hearts subjected to ischemia/reperfusion
Ji-Kang Fang et al.
FEBS LETTERS (2007)
Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons
Mark J. Barsoum et al.
EMBO JOURNAL (2006)
Protein kinase A-mediated phosphorylation modulates cytochrome c oxidase function and augments hypoxia and myocardial ischemia-related injury
SK Prabu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Rotenone model of Parkinson disease - Multiple brain mitochondria dysfunctions after short term systemic rotenone intoxication
A Panov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
R Betarbet et al.
NATURE NEUROSCIENCE (2000)
Share Paper
